Hi shreyab
Reasons why they need to do a CR are no doubt correct, but I question the timing of managements decision to do it now. As always, in hindsight, should have been done while SP was above $1. I also have my suspicions/thoughts as to why it is being done now, and also as to why the SP has been driven so low, and by whom?
Notwithstanding the fact that a CR may need to be done soon, I thought they had a $50 mill debt facility for Andash ( which is looking more and more unlikely each passing day ). Surely Jervois can wait a few months. Looks like they're trying to run before they can walk.
Get the first pour out of the way, get a definitive answer on Andash (NOW) and then look at progressing the Aussie projects.
Who is going to be able to participate in the CR? I certainly can't afford to buy anymore, but as a fairly long term investor (or mug), why was I not offered the opportunity to be involved?
Trading should commence this morning, and figures of 60cents are a "bit scary", but I think the CR would have been done at 85cents. Surely they can't do one at a 15% lower price than the last closing price?
All will be revealed soon!
- Forums
- ASX - By Stock
- KGL
- trading halt
trading halt, page-94
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KGL (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.56M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 171518 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 74758 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 171518 | 0.105 |
4 | 575000 | 0.100 |
1 | 89600 | 0.095 |
2 | 111125 | 0.090 |
1 | 6000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 74758 | 3 |
0.115 | 40497 | 1 |
0.120 | 242648 | 1 |
0.130 | 33 | 1 |
0.180 | 5000 | 1 |
Last trade - 07.18am 16/07/2024 (20 minute delay) ? |
Featured News
KGL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online